IRON · Disc Medicine Inc
United States · RS rating 13 · As of 2026-10-14
| Price | 55.74 USD |
|---|---|
| 1-day change | -1.5% |
| RS rating (overall / 1M / 3M / 12M) | 13 / 14 / 15 / 25 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 29 / 18 / 21 |
| Industry group (rank) | Medical-Biomed/Biotech (167) |
| EPS growth Q/Q | +6.7% |
| Sales growth Q/Q | – |
| Distance from 52-week high | +40.8% |
| Market cap (USD) | $2.6B |